Cargando…
A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats
PURPOSE: Enobosarm (EN), a selective androgen receptor modulator and raloxifene (RAL), a selective estrogen receptor modulator, have been shown to improve bone tissue in osteoporotic males. The present study evaluated the effects of a combination therapy of EN and RAL on bone properties in orchiecto...
Autores principales: | Komrakova, M., Büchler, G., Böker, K. O., Lehmann, W., Schilling, A. F., Roch, P. J., Taudien, S., Hoffmann, D. B., Sehmisch, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646546/ https://www.ncbi.nlm.nih.gov/pubmed/35867330 http://dx.doi.org/10.1007/s40618-022-01865-9 |
Ejemplares similares
-
Combination of selective androgen and estrogen receptor modulators in orchiectomized rats
por: Roch, P. J., et al.
Publicado: (2022) -
Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model
por: Böker, K. O., et al.
Publicado: (2023) -
Effect of Selective Androgen Receptor Modulator Enobosarm on Bone Healing in a Rat Model for Aged Male Osteoporosis
por: Komrakova, Marina, et al.
Publicado: (2020) -
Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat
por: Tezval, M., et al.
Publicado: (2011) -
Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats
por: Stuermer, E. K., et al.
Publicado: (2009)